Related Experiment Video
Updated: Mar 22, 2026

08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.7K
The effect on drug development of the National Cancer Institute's Cancer Therapy Evaluation Program
1National Cancer Institute, Rockville, Maryland.
Clinical Advances in Hematology & Oncology : H&O
|April 9, 2016
Abstract
No abstract available in PubMed .

